Phathom Pharmaceuticals, Inc. PHAT
5.21 USD +0.13 (+2.46%)
Nov 6, 2026, 2:36 PM EST
5.04 Day range 5.22
5.08 52-week range 18.08
- YTD
- -68.63%
- 1 year
- -60.08%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 175.11M | 55.25M | 682.00K | 0 | 0 | |
| 152.51M | 47.28M | 515.00K | 0 | 0 | |
| -159.99M | -277.47M | -167.31M | -172.44M | -135.08M | |
| -221.25M | -334.33M | -201.59M | -197.72M | -143.88M | |
| -3.03 | -5.29 | -3.93 | -5.05 | -3.89 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 132.83M | 300.13M | 384.26M | 155.89M | 183.42M | |
| 259.15M | 378.32M | 413.84M | 164.81M | 189.43M | |
| 697.32M | 631.90M | 486.60M | 239.62M | 117.28M | |
| 561.92M | 535.17M | 438.85M | 206.59M | 91.34M | |
| -438.17M | -253.58M | -72.76M | -74.81M | 72.16M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -166.78M | -266.77M | -137.58M | -146.53M | -148.46M | |
| -229.00K | -135.00K | -1.63M | -1.04M | -328.00K | |
| -288.00K | 182.77M | 367.58M | 120.04M | 44.71M | |
| -229.00K | -135.00K | -1.63M | -1.04M | -328.00K | |
| -167.29M | -84.13M | 228.37M | -27.53M | -104.08M |